Butobarbital
From Wikipedia, the free encyclopedia
Jump to: navigation, search
| Clinical data | |
|---|---|
| Trade names | Soneryl |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration |
Oral |
| ATC code | N05CA03 (WHO) |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal |
| Identifiers | |
|
|
| CAS Number | 77-28-1 |
| PubChem (CID) | 6473 |
| DrugBank | DB01353 |
| ChemSpider | 6229 |
| UNII | OHZ8QAW6YC |
| KEGG | D02618 |
| ChEMBL | CHEMBL404422 |
| ECHA InfoCard | 100.000.928 |
| Chemical and physical data | |
| Formula | C10H16N2O3 |
| Molar mass | 212.246 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
Butobarbital (BAN), also called butobarbitone or butethal, Soneryl, and Neonal,[1] is a hypnotic drug which is a barbiturate derivative. It was developed by Poulenc Brothers (now part of Rhône Poulenc) in 1921.[2]
References[edit]
- ^ International Drug Names
- ^ DE Patent 481129
| Alcohols | |
|---|---|
| Barbiturates |
|
| Benzodiazepines |
|
| Carbamates | |
| Flavonoids |
|
| Imidazoles | |
| Kava constituents | |
| Monoureides | |
| Neuroactive steroids |
|
| Nonbenzodiazepines |
|
| Phenols | |
| Piperidinediones | |
| Pyrazolopyridines | |
| Quinazolinones | |
| Volatiles/gases |
|
| Others/unsorted |
|
|
See also: GABAergics
|
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |